Text Size
40 studies found for:    NIAID | Open Studies | Exclude Unknown

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: HIV-1 Multiantigen pDNA Vaccine;   Biological: Human IL-12 pDNA;   Procedure: In Vivo Electroporation using the TriGri;   Biological: rVSVIN HIV Gag Vaccine;   Biological: Placebo
3 Recruiting Volunteer Screening for Vaccine and Antivirals Clinical Trials
Condition: Healthy Volunteer
Intervention:
4 Recruiting Immune Responses to Smallpox Vaccination
Condition: Smallpox Vaccine
Intervention:
5 Recruiting Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route;   Biological: Ad4-H5-vaccination-oral route
6 Recruiting Intranasal AD4-H5-VTN as an Adenovirus Vaccine
Condition: Healthy Volunteer
Intervention: Biological: Ad4-H5-Vtn
7 Recruiting Antibody Production in Immune Disorders
Condition: Immunologic Disease
Intervention:
8 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar 13 (PVC13)
9 Recruiting Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-MAG vaccine;   Biological: IL-12 pDNA adjuvant;   Biological: VSV HIV gag vaccine;   Biological: Placebo
10 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
11 Recruiting Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
Condition: Human Parainfluenza Virus 2
Interventions: Biological: Standard Dose HPIV2 Vaccine;   Biological: Low dose HPIV2 vaccine;   Other: Placebo
12 Recruiting Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults
Condition: Influenza A Subtype H7N7 Infection
Intervention: Biological: Monovalent Influenza Subvirion Vaccine, H7N7
13 Recruiting Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Condition: Influenza, Human
Interventions: Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca);   Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca);   Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®);   Biological: Vaccine placebo (Leibovitz-15 [L-15]);   Biological: Vaccine placebo (FluMist®)
14 Not yet recruiting Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine
15 Recruiting LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine
Condition: Leishmaniasis
Interventions: Drug: MPL-SE;   Drug: SE;   Biological: LEISH-F3;   Drug: GLA-SE
16 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
17 Recruiting Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine
Condition: Metapneumovirus
Interventions: Biological: 10^6 PFU rHMPV-Pa vaccine;   Biological: 10^5 PFU rHMPV-Pa vaccine;   Biological: Placebo Vaccine
18 Not yet recruiting Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
19 Recruiting Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women
Condition: HIV Infections
Interventions: Biological: Quadrivalent HPV Vaccine;   Biological: Placebo Vaccine for Male Participants Only;   Biological: Placebo Vaccine for Female Participants Only
20 Recruiting Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Condition: Human Papillomavirus
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years